[D300e Case Study] zPREDICTA Inc. (San Jose, USA)
Creation of 3D technology for efficient research and development of pharmaceuticals.
zPREDICTA, based in San Jose, USA, has developed new 3D technology that enables a reconstituted organ (r-Organ) platform, which mimics the original structure of human tissues in an organ-specific and disease-specific manner, taking into account human physiology and organ-specific microenvironments. *For more details, please refer to the PDF document or feel free to contact us.*
basic information
【Benefits of Introduction】 By introducing the D300e, the setup time that previously took 3.5 hours manually can be completed in just 15 minutes, and the processing time for 60 plates has been reduced from 26 hours to 2.5 hours. Additionally, the amount of compounds used has decreased by 80%, and waste has been reduced by more than 2,000 times. *For more details, please refer to the PDF document or feel free to contact us.*
Price range
Delivery Time
Applications/Examples of results
For more details, please refer to the PDF document or feel free to contact us.
Related Videos
catalog（5）
Download All Catalogs
